Copyright
©2012 Baishideng Publishing Group Co.
World J Gastrointest Pharmacol Ther. Feb 6, 2012; 3(1): 1-6
Published online Feb 6, 2012. doi: 10.4292/wjgpt.v3.i1.1
Published online Feb 6, 2012. doi: 10.4292/wjgpt.v3.i1.1
Table 4 Eradication rates excluding patients whose Helicobacter pylori status was checked only by serological test
| Treatment groups | ||||||
| LACM7 | LAC7 | P value | ||||
| Eradication | n | % | n | % | ||
| ITT analysis | Success | 49 | 94.2 | 30 | 68.2 | 0.0009 |
| Failure | 3 | 5.8 | 14 | 31.8 | ||
| Per protocol analysis | Success | 49 | 98.0 | 30 | 75.0 | 0.0009 |
| Failure | 1 | 2.0 | 10 | 25.0 | ||
- Citation: Yanai A, Sakamoto K, Akanuma M, Ogura K, Maeda S. Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication: A randomized study in Japan. World J Gastrointest Pharmacol Ther 2012; 3(1): 1-6
- URL: https://www.wjgnet.com/2150-5349/full/v3/i1/1.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v3.i1.1